Michael F Bode1, Nigel Mackman2. 1. University of North Carolina, Division of Cardiology, Department of Medicine; 160 Dental Circle, CB #7075, 6025 Burnett-Womack-Bldg., Chapel Hill, NC 27514-7075, USA. Electronic address: michael_bode@med.unc.edu. 2. University of North Carolina, Division of Hematology and Oncology, Department of Medicine; McAllister Heart Institute, 111 Mason Farm Road, 2312C Medical Biomolecular Research Bldg., CB #7126, Chapel Hill, NC 27599-7126, USA. Electronic address: nigel_mackman@med.unc.edu.
Abstract
INTRODUCTION: Mice with a complete absence of tissue factor (TF) die during embryonic development whereas mice with low levels of TF (Low-TF mice) survive to adulthood. Low-TF mice exhibit spontaneous hemorrhage in various organs, including the lung. In contrast, mice can survive without protease-activated receptor (PAR)-4, which is the major thrombin receptor on mouse platelets. We determined the effect of combining a deficiency PAR-4 (primary hemostasis) with a deficiency in TF (secondary hemostasis) on embryonic development and survival of adult mice. MATERIALS AND METHODS: Low-TF mice (mTF-/-, hTF+/+) were crossed with PAR-4-/- mice to generate heterozygous mice (mTF+/-, hTF+/-, PAR-4+/-). These mice were intercrossed to generate Low-TF mice lacking PAR-4. Mice surviving to wean were genotyped and survival was monitored for 6months. RESULTS: We observed the expected number of Low-TF,PAR-4-/- mice at wean indicating survival in utero and after birth. However, an absence of PAR-4 was associated with premature death of all Low-TF,PAR-4-/- mice in the 6month observational period. This compares with 40% death of the Low-TF,PAR-4+/+ mice (p=0.003). Low-TF,PAR-4+/- mice had an intermediate phenotype with 55% of the mice dying within 6months. The primary cause of mortality of Low-TF,PAR-4-/- mice was pulmonary hemorrhage. CONCLUSIONS: Low-TF,PAR-4-/- mice survive into adulthood, but combining a deficiency of primary hemostasis (PAR-4 deficiency) with secondary hemostasis (low levels of TF) leads to premature death primarily due to pulmonary hemorrhage.
INTRODUCTION:Mice with a complete absence of tissue factor (TF) die during embryonic development whereas mice with low levels of TF (Low-TFmice) survive to adulthood. Low-TFmice exhibit spontaneous hemorrhage in various organs, including the lung. In contrast, mice can survive without protease-activated receptor (PAR)-4, which is the major thrombin receptor on mouse platelets. We determined the effect of combining a deficiency PAR-4 (primary hemostasis) with a deficiency in TF (secondary hemostasis) on embryonic development and survival of adult mice. MATERIALS AND METHODS: Low-TFmice (mTF-/-, hTF+/+) were crossed with PAR-4-/- mice to generate heterozygous mice (mTF+/-, hTF+/-, PAR-4+/-). These mice were intercrossed to generate Low-TFmice lacking PAR-4. Mice surviving to wean were genotyped and survival was monitored for 6months. RESULTS: We observed the expected number of Low-TF,PAR-4-/- mice at wean indicating survival in utero and after birth. However, an absence of PAR-4 was associated with premature death of all Low-TF,PAR-4-/- mice in the 6month observational period. This compares with 40% death of the Low-TF,PAR-4+/+ mice (p=0.003). Low-TF,PAR-4+/- mice had an intermediate phenotype with 55% of the mice dying within 6months. The primary cause of mortality of Low-TF,PAR-4-/- mice was pulmonary hemorrhage. CONCLUSIONS:Low-TF,PAR-4-/- mice survive into adulthood, but combining a deficiency of primary hemostasis (PAR-4 deficiency) with secondary hemostasis (low levels of TF) leads to premature death primarily due to pulmonary hemorrhage.
Authors: Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson Journal: N Engl J Med Date: 2011-11-13 Impact factor: 91.245
Authors: P Carmeliet; N Mackman; L Moons; T Luther; P Gressens; I Van Vlaenderen; H Demunck; M Kasper; G Breier; P Evrard; M Müller; W Risau; T Edgington; D Collen Journal: Nature Date: 1996-09-05 Impact factor: 49.962
Authors: H Weiler-Guettler; P D Christie; D L Beeler; A M Healy; W W Hancock; H Rayburn; J M Edelberg; R D Rosenberg Journal: J Clin Invest Date: 1998-05-01 Impact factor: 14.808
Authors: R Pawlinski; M Tencati; T Holscher; B Pedersen; T Voet; R E Tilley; P Marynen; N Mackman Journal: J Thromb Haemost Date: 2007-08 Impact factor: 5.824
Authors: W Y Sun; D P Witte; J L Degen; M C Colbert; M C Burkart; K Holmbäck; Q Xiao; T H Bugge; S J Degen Journal: Proc Natl Acad Sci U S A Date: 1998-06-23 Impact factor: 11.205
Authors: J Xue; Q Wu; L A Westfield; E A Tuley; D Lu; Q Zhang; K Shim; X Zheng; J E Sadler Journal: Proc Natl Acad Sci U S A Date: 1998-06-23 Impact factor: 11.205
Authors: Susanna H M Sluka; Simon F Stämpfli; Alexander Akhmedov; Tanja Klein-Rodewald; Adrián Sanz-Moreno; Marion Horsch; Paula Grest; Andrea S Rothmeier; Birgit Rathkolb; Anja Schrewe; Johannes Beckers; Frauke Neff; Eckhard Wolf; Giovanni G Camici; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Thomas F Lüscher; Wolfram Ruf; Felix C Tanner Journal: Haematologica Date: 2019-09-05 Impact factor: 9.941
Authors: Steven P Grover; Clare M Schmedes; Alyson C Auriemma; Emily Butler; Molly L Parrish; Adam Miszta; Audrey C Cleuren; Mayken Visser; Stefan Heitmeier; Jens J Posma; Henri M Spronk; Silvio Antoniak; Alisa S Wolberg; Rafal Pawlinski; David Gailani; Nigel Mackman Journal: Blood Adv Date: 2020-01-14
Authors: Sol Schulman; Emale El-Darzi; Mary Hc Florido; Max Friesen; Glenn Merrill-Skoloff; Marisa A Brake; Calvin R Schuster; Lin Lin; Randal J Westrick; Chad A Cowan; Robert Flaumenhaft; Willem H Ouwehand; Kathelijne Peerlinck; Kathleen Freson; Ernest Turro; Bruce Furie Journal: J Clin Invest Date: 2020-10-01 Impact factor: 14.808